Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogen Peroxide | 3 | 2025 | 190 | 0.950 |
Why?
|
| Water Pollutants, Chemical | 4 | 2014 | 171 | 0.850 |
Why?
|
| Cell Movement | 1 | 2025 | 655 | 0.690 |
Why?
|
| Nanoparticles | 4 | 2014 | 460 | 0.660 |
Why?
|
| Artemia | 4 | 2014 | 13 | 0.650 |
Why?
|
| MicroRNAs | 1 | 2025 | 518 | 0.590 |
Why?
|
| Zinc Oxide | 2 | 2014 | 25 | 0.510 |
Why?
|
| Nigella sativa | 2 | 2005 | 2 | 0.440 |
Why?
|
| Goldfish | 1 | 2014 | 18 | 0.430 |
Why?
|
| Copper | 1 | 2014 | 134 | 0.390 |
Why?
|
| Titanium | 1 | 2012 | 48 | 0.360 |
Why?
|
| Cadmium | 2 | 2011 | 56 | 0.340 |
Why?
|
| Toluene | 2 | 2007 | 11 | 0.300 |
Why?
|
| Breast Neoplasms | 3 | 2005 | 1723 | 0.280 |
Why?
|
| Benzothiazoles | 2 | 2007 | 26 | 0.270 |
Why?
|
| Hepatoblastoma | 1 | 2007 | 3 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2014 | 1124 | 0.250 |
Why?
|
| Dialysis Solutions | 1 | 2026 | 2 | 0.250 |
Why?
|
| Hepatocytes | 1 | 2007 | 80 | 0.250 |
Why?
|
| Parathyroid Hormone | 1 | 2026 | 41 | 0.240 |
Why?
|
| Energy Metabolism | 1 | 2007 | 187 | 0.230 |
Why?
|
| DNA Repair | 1 | 2007 | 198 | 0.230 |
Why?
|
| Parvoviridae Infections | 1 | 2025 | 2 | 0.230 |
Why?
|
| Parvovirus B19, Human | 1 | 2025 | 2 | 0.230 |
Why?
|
| Malondialdehyde | 3 | 2014 | 42 | 0.230 |
Why?
|
| Fibroblasts | 1 | 2007 | 281 | 0.220 |
Why?
|
| Renal Dialysis | 1 | 2026 | 131 | 0.220 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 228 | 0.220 |
Why?
|
| Arsenic | 1 | 2007 | 155 | 0.220 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1019 | 0.210 |
Why?
|
| Plant Extracts | 2 | 2005 | 302 | 0.200 |
Why?
|
| Diacetyl | 1 | 2003 | 2 | 0.200 |
Why?
|
| Salmonella typhimurium | 1 | 2003 | 40 | 0.190 |
Why?
|
| Anemia, Sickle Cell | 1 | 2025 | 187 | 0.190 |
Why?
|
| Pesticides | 1 | 2003 | 62 | 0.190 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 532 | 0.180 |
Why?
|
| Hot Temperature | 1 | 2003 | 141 | 0.180 |
Why?
|
| Staphylococcus aureus | 1 | 2003 | 94 | 0.180 |
Why?
|
| Soil Pollutants | 1 | 2003 | 105 | 0.170 |
Why?
|
| Cell Survival | 4 | 2007 | 945 | 0.170 |
Why?
|
| Oxidative Stress | 5 | 2014 | 1003 | 0.170 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 495 | 0.170 |
Why?
|
| Environmental Exposure | 1 | 2003 | 256 | 0.160 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2018 | 19 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 137 | 0.140 |
Why?
|
| Humans | 12 | 2026 | 43102 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 196 | 0.120 |
Why?
|
| Bioprosthesis | 2 | 2005 | 5 | 0.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2005 | 26 | 0.110 |
Why?
|
| Heart Valve Prosthesis | 2 | 2005 | 44 | 0.110 |
Why?
|
| Lipid Peroxidation | 2 | 2012 | 140 | 0.110 |
Why?
|
| Lethal Dose 50 | 2 | 2007 | 32 | 0.110 |
Why?
|
| Particle Size | 2 | 2013 | 272 | 0.110 |
Why?
|
| Animals | 9 | 2014 | 16992 | 0.110 |
Why?
|
| Cytoprotection | 2 | 2007 | 36 | 0.110 |
Why?
|
| Food Chain | 1 | 2014 | 20 | 0.110 |
Why?
|
| Liver | 2 | 2011 | 511 | 0.100 |
Why?
|
| Aluminum Oxide | 1 | 2013 | 11 | 0.100 |
Why?
|
| Tissue Distribution | 1 | 2014 | 240 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 2676 | 0.090 |
Why?
|
| Chordae Tendineae | 1 | 2011 | 1 | 0.090 |
Why?
|
| Rheumatic Heart Disease | 1 | 2011 | 4 | 0.090 |
Why?
|
| Cadmium Compounds | 1 | 2011 | 7 | 0.090 |
Why?
|
| Zinc | 1 | 2012 | 131 | 0.090 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 46 | 0.090 |
Why?
|
| Selenium Compounds | 1 | 2011 | 11 | 0.090 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2011 | 22 | 0.090 |
Why?
|
| Mitral Valve | 1 | 2011 | 36 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2011 | 54 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2007 | 1621 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2014 | 469 | 0.080 |
Why?
|
| Kidney | 1 | 2011 | 372 | 0.070 |
Why?
|
| Aortic Valve | 2 | 2005 | 38 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2007 | 283 | 0.070 |
Why?
|
| Rats | 5 | 2011 | 3735 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2011 | 230 | 0.070 |
Why?
|
| Cell Size | 1 | 2007 | 46 | 0.060 |
Why?
|
| Water | 2 | 2006 | 316 | 0.060 |
Why?
|
| Mississippi | 2 | 2006 | 129 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2007 | 104 | 0.060 |
Why?
|
| Water Supply | 1 | 2006 | 60 | 0.060 |
Why?
|
| Hydrochloric Acid | 1 | 2026 | 3 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2011 | 1604 | 0.060 |
Why?
|
| Buffers | 1 | 2026 | 17 | 0.060 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2026 | 14 | 0.060 |
Why?
|
| France | 1 | 2026 | 23 | 0.060 |
Why?
|
| Rivers | 1 | 2006 | 51 | 0.060 |
Why?
|
| Citric Acid | 1 | 2026 | 15 | 0.060 |
Why?
|
| Female | 6 | 2026 | 24698 | 0.060 |
Why?
|
| Male | 7 | 2026 | 23409 | 0.060 |
Why?
|
| Water Microbiology | 1 | 2006 | 81 | 0.060 |
Why?
|
| Acetates | 1 | 2026 | 32 | 0.060 |
Why?
|
| Reference Values | 2 | 2003 | 211 | 0.060 |
Why?
|
| Androstenedione | 2 | 2003 | 19 | 0.060 |
Why?
|
| Temperature | 2 | 2006 | 313 | 0.060 |
Why?
|
| Heart Valve Diseases | 1 | 2005 | 15 | 0.060 |
Why?
|
| Dihydrotestosterone | 2 | 2003 | 28 | 0.060 |
Why?
|
| Cell Line | 2 | 2007 | 1410 | 0.060 |
Why?
|
| Solvents | 1 | 2005 | 113 | 0.060 |
Why?
|
| Sudan | 1 | 2025 | 3 | 0.060 |
Why?
|
| Immunoglobulin M | 1 | 2025 | 86 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 220 | 0.050 |
Why?
|
| DNA Damage | 1 | 2007 | 356 | 0.050 |
Why?
|
| Testosterone | 2 | 2003 | 211 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 224 | 0.050 |
Why?
|
| Adult | 3 | 2026 | 13872 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2025 | 259 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2025 | 458 | 0.050 |
Why?
|
| Bacteria | 1 | 2006 | 293 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2025 | 311 | 0.050 |
Why?
|
| Ethanol | 1 | 2005 | 224 | 0.050 |
Why?
|
| Adenosarcoma | 1 | 2003 | 1 | 0.050 |
Why?
|
| Renal Artery | 1 | 2003 | 7 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 67 | 0.050 |
Why?
|
| Cell Membrane Permeability | 1 | 2003 | 57 | 0.050 |
Why?
|
| Larva | 2 | 2013 | 133 | 0.050 |
Why?
|
| Food Contamination | 1 | 2003 | 57 | 0.050 |
Why?
|
| Seeds | 1 | 2003 | 46 | 0.050 |
Why?
|
| Crops, Agricultural | 1 | 2003 | 36 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2025 | 306 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2026 | 1063 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2003 | 75 | 0.050 |
Why?
|
| Androgens | 1 | 2003 | 106 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 311 | 0.050 |
Why?
|
| Cadmium Chloride | 1 | 2002 | 10 | 0.050 |
Why?
|
| Aorta | 1 | 2003 | 198 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 508 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1070 | 0.040 |
Why?
|
| Thiazoles | 1 | 2002 | 76 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 611 | 0.040 |
Why?
|
| Phylogeny | 1 | 2025 | 769 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2002 | 123 | 0.040 |
Why?
|
| Oxides | 1 | 2002 | 100 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 220 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2007 | 1455 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2025 | 1546 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 1612 | 0.040 |
Why?
|
| Myocardium | 1 | 2002 | 263 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 1081 | 0.040 |
Why?
|
| Aged | 3 | 2026 | 8214 | 0.040 |
Why?
|
| Young Adult | 2 | 2025 | 5080 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2003 | 1234 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 64 | 0.040 |
Why?
|
| Cytokines | 1 | 2002 | 678 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2018 | 346 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2011 | 1766 | 0.030 |
Why?
|
| Child | 1 | 2025 | 3443 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 1067 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 986 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2005 | 100 | 0.030 |
Why?
|
| Risk Factors | 1 | 2003 | 3994 | 0.030 |
Why?
|
| Ecotoxicology | 1 | 2013 | 14 | 0.030 |
Why?
|
| Middle Aged | 2 | 2026 | 12222 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 66 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2013 | 83 | 0.030 |
Why?
|
| Adolescent | 1 | 2025 | 6081 | 0.030 |
Why?
|
| Seawater | 1 | 2013 | 54 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2011 | 23 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2011 | 104 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1568 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 863 | 0.020 |
Why?
|
| Filtration | 1 | 2006 | 17 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2006 | 55 | 0.020 |
Why?
|
| Quality Control | 1 | 2006 | 42 | 0.020 |
Why?
|
| Recreation | 1 | 2006 | 43 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2005 | 3 | 0.010 |
Why?
|
| Reoperation | 1 | 2005 | 34 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2005 | 47 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 388 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 218 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 47 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2006 | 230 | 0.010 |
Why?
|
| Echocardiography | 1 | 2005 | 167 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 368 | 0.010 |
Why?
|
| Drug Implants | 1 | 2003 | 20 | 0.010 |
Why?
|
| Calcium Phosphates | 1 | 2003 | 15 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 39 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2002 | 165 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 1600 | 0.010 |
Why?
|
| Arsenicals | 1 | 2002 | 87 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 490 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2003 | 277 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 384 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 2853 | 0.010 |
Why?
|